BIOCARDIA

Website Links

Description

BioCardia, Inc., headquartered in San Carlos, CA is a privately held company that has developed percutaneous delivery systems for regenerative biologic therapies to treat cardiovascular disease. The Company's initial products, including Helical Infusion System, intended to provide new therapeutic options for patients with heart failure and chronic myocardial ischemia, and Morph® vascular access catheters, commercially available for complex vascular procedures.

About BioCardia Founded in 1999 and headquartered in San Carlos, California, privately held BioCardia, Inc. is a leader in cardiac regeneration therapies. BioCardia is the corporate sponsor of the TAC-HFT and TABMMI stem cell trials. BioCardia provides Helix™ and Morph® catheter systems to partners for other leading biological based therapies to treat cardiovascular disease. BioCardia also markets the Morph® catheter directly to interventional cardiologists, cardiac electrophysiologists, vascular surgeons, and interventional radiologists at more than 200 hospitals in the United States.

BioCardia, Inc., headquartered in San Carlos, CA is a privately held company developing regenerative biologic therapies to treat cardiovascular disease. The Company's current products include the Helical Infusion Catheter System and the Morph steerable guide and sheath catheter portfolio. BioCardia partners with other biotherapeutic companies to provide its Helical Infusion Catheter System and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction.

About BioCardia® BioCardia, Inc., headquartered in San Carlos, CA is a privately held company developing regenerative biologic therapies to treat cardiovascular disease. The Company's current products include the Helix™ Transendocardial Delivery System and the Morph ® steerable guide and sheath catheter portfolio. BioCardia also partners with other biotherapeutic companies to provide its Helix Systems and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction.

BioCardia was founded in 2002 to develop biointerventional solutions for heart failure, chronic myocardial ischemia and acute myocardial infarction and is headquartered in San Carlos, California.

Fact sheet

Products & services

Similar companies nearby